Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Milestone Scientific's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $8.01 Mil. Milestone Scientific's Total Assets for the quarter that ended in Dec. 2023 was $11.37 Mil.
Therefore, Milestone Scientific's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.71.
The historical rank and industry rank for Milestone Scientific's Equity-to-Asset or its related term are showing as below:
MLSS'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.24 Med: 0.73 Max: 0.84
Current: 0.71
During the past 13 years, the highest Equity to Asset Ratio of Milestone Scientific was 0.84. The lowest was 0.24. And the median was 0.73.
MLSS's Equity-to-Asset is ranked better than 58.87% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs MLSS: 0.71
Milestone Scientific Equity-to-Asset Historical Data
The historical data trend for Milestone Scientific's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Milestone Scientific's Equity-to-Asset
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Equity-to-Asset falls into.
Milestone Scientific Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Milestone Scientific's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Milestone Scientific Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Milestone Scientific's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Milestone Scientific (Milestone Scientific) Business Description
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MLSS has been successfully added to your 